annual cash & cash equivalents:
$411.29M+$60.10M(+17.11%)Summary
- As of today (August 4, 2025), APLS annual cash & cash equivalents is $411.29 million, with the most recent change of +$60.10 million (+17.11%) on December 31, 2024.
- During the last 3 years, APLS annual cash & cash equivalents has fallen by -$228.90 million (-35.76%).
- APLS annual cash & cash equivalents is now -35.76% below its all-time high of $640.19 million, reached on December 31, 2021.
Performance
APLS Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$370.04M+$11.64M(+3.25%)Summary
- As of today (August 4, 2025), APLS quarterly cash & cash equivalents is $370.04 million, with the most recent change of +$11.64 million (+3.25%) on June 30, 2025.
- Over the past year, APLS quarterly cash & cash equivalents has increased by +$9.95 million (+2.76%).
- APLS quarterly cash & cash equivalents is now -51.63% below its all-time high of $765.08 million, reached on March 31, 2023.
Performance
APLS quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
APLS Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.1% | +2.8% |
| 3 y3 years | -35.8% | -38.8% |
| 5 y5 years | +16.9% | +16.6% |
APLS Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -35.8% | +17.1% | -51.6% | +13.5% |
| 5 y | 5-year | -35.8% | +17.1% | -51.6% | +39.4% |
| alltime | all time | -35.8% | +8543.5% | -51.6% | +3588.5% |
APLS Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $370.04M(+3.2%) |
| Mar 2025 | - | $358.39M(-12.9%) |
| Dec 2024 | $411.29M(+17.1%) | $411.29M(+3.6%) |
| Sep 2024 | - | $396.86M(+10.2%) |
| Jun 2024 | - | $360.09M(+10.5%) |
| Mar 2024 | - | $325.92M(-7.2%) |
| Dec 2023 | $351.19M(-36.4%) | $351.19M(-22.4%) |
| Sep 2023 | - | $452.41M(-26.6%) |
| Jun 2023 | - | $616.26M(-19.5%) |
| Mar 2023 | - | $765.08M(+38.7%) |
| Dec 2022 | $551.80M(-13.8%) | $551.80M(-5.5%) |
| Sep 2022 | - | $584.19M(-3.4%) |
| Jun 2022 | - | $604.49M(-4.6%) |
| Mar 2022 | - | $633.46M(-1.1%) |
| Dec 2021 | $640.19M(+13.2%) | $640.19M(+125.6%) |
| Sep 2021 | - | $283.75M(+4.8%) |
| Jun 2021 | - | $270.76M(+2.0%) |
| Mar 2021 | - | $265.44M(-53.1%) |
| Dec 2020 | $565.78M | $565.78M(+36.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $415.56M(+30.9%) |
| Jun 2020 | - | $317.35M(-24.1%) |
| Mar 2020 | - | $417.88M(+18.7%) |
| Dec 2019 | $351.99M(+99.7%) | $351.99M(-18.9%) |
| Sep 2019 | - | $433.99M(+50.1%) |
| Jun 2019 | - | $289.13M(+0.3%) |
| Mar 2019 | - | $288.25M(+63.5%) |
| Dec 2018 | $176.27M(+0.4%) | $176.27M(-20.1%) |
| Sep 2018 | - | $220.64M(-13.1%) |
| Jun 2018 | - | $253.84M(+66.0%) |
| Mar 2018 | - | $152.93M(-12.9%) |
| Dec 2017 | $175.64M(+606.4%) | $175.64M(+1237.1%) |
| Sep 2017 | - | $13.14M(-74.8%) |
| Jun 2017 | - | $52.19M(+109.9%) |
| Dec 2016 | $24.86M(-30.9%) | $24.86M(-30.9%) |
| Dec 2015 | $36.00M(+164.3%) | $36.00M(+258.9%) |
| Sep 2015 | - | $10.03M(-32.5%) |
| Jun 2015 | - | $14.87M(+9.1%) |
| Dec 2014 | $13.62M(+186.3%) | $13.62M |
| Dec 2013 | $4.76M | - |
FAQ
- What is Apellis Pharmaceuticals, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
- What is Apellis Pharmaceuticals, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
What is Apellis Pharmaceuticals, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of APLS is $411.29M
What is the all time high annual cash & cash equivalents for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high annual cash & cash equivalents is $640.19M
What is Apellis Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, APLS annual cash & cash equivalents has changed by +$60.10M (+17.11%)
What is Apellis Pharmaceuticals, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of APLS is $370.04M
What is the all time high quarterly cash & cash equivalents for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high quarterly cash & cash equivalents is $765.08M
What is Apellis Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, APLS quarterly cash & cash equivalents has changed by +$9.95M (+2.76%)